How Can We Expand Eligibility Criteria for Diffuse Large B-Cell Lymphoma Clinical Trials to Serve More Patients?

This podcast considers the impact of exclusion criteria on clinical trials, generalizability, and the complexity of modernizing eligibility while maintaining trial integrity.

Mar 25^th • 10 mins listen

Why Genetic Testing Should Be Standard in Prostate Cancer

Labcorp, Rebecca Previs, Sarah Young, genetic counselor, genetic testing, prostate cancer, urologic oncology, germline, somatic, PARP inhibitors, digital

Hear why universal genetic testing matters in prostate cancer — plus, how it can improve treatment, equity, and outcomes for patients everywhere.

May 18^th • 19 mins listen